Such-Lupe

Ad hoc and press releases

Here, we have compiled the press and ad hoc releases from the past years. All releases can be viewed directly on the screen or downloaded in PDF format.

2012 

11/08/2012
Corporate News
STADA records an operationally good result in the first nine months of 2012
More information
 
09/25/2012
Ad hoc update

Ad hoc release according to § 15 WpHG:

STADA: sale of two Russian production facilities successfully closed – personnel reduction goal in the context of “STADA – build the future” reached earlier than planned
More information
 
09/10/2012
Corporate News
STADA Group takes a leading position in the third Barmer GEK discount agreement round
More information
 
08/15/2012
Ad hoc update

Ad hoc release according to § 15 WpHG:

STADA signs contract on the sale of two Russian production facilities and thus completes another significant step in the context of “STADA – build the future”
More information
 
08/08/2012
Corporate News
STADA records positive business development in the first half of 2012 – outlook remains positive to 2014
More information
 
08/07/2012
Ad hoc release

Ad hoc release according to § 15 WpHG:

STADA: Sale of two Russian production facilities in the context of the production restructuring according to “STADA – build the future” expected within Q3/2012
More information
 
06/04/2012
Corporate News
STADA sales companies once again successful in tenders for discount agreements in the German generics market – very good results in the second Barmer GEK tender round
More information
 
05/30/2012
Corporate News
STADA AGM 2012: Executive Board expects further growth in Group sales and earnings – positive outlook until 2014 confirmed
More information
 
05/23/2012
Corporate News
STADA sales companies achieve very good results in the 8th AOK tender round in the German generics market
More information
 
05/10/2012
Corporate News
STADA: Excellent start in Q1/2012 – Increase in all adjusted key earnings figures – Reported key earnings figures burdened by planned one-time special effects – Positive outlook until 2014 confirmed
More information
 
04/26/2012
Corporate News
Patrick Meschenmoser heads Media Relations at STADA
More information
 
03/29/2012
Corporate News
STADA: Operationally successful financial year 2011 – Increase in all adjusted key earnings figures – Reported key earnings figures decrease due to the high burdening one-time special effects – Positive outlook until 2014
More information
 
03/27/2012
Corporate News
STADA founds a subsidiary in Australia – business activities expected to commence in the third quarter of 2012
More information
 
03/06/2012
Corporate News
STADA with a new Internet presence and its own YouTube channel
More information
 
03/01/2012
Ad hoc release

Ad hoc release according to § 15 WpHG:

STADA: 2011 preliminary results confirm operationally successful year – low net income due to high burdening one-time special effects – dividend to remain unchanged at EUR 0.37 per ordinary share – positive outlook until 2014
More information
 
02/06/2012
Ad hoc release

Ad hoc release according to § 15 WpHG:

STADA sells Irish production facility and thus continues to be in line with planning for the implementation of
More information
 
01/31/2012
Ad hoc update

Ad hoc release according to § 15 WpHG:

STADA: Purchase of a branded product portfolio for the EU markets in Central Europe successfully concluded
More information
 
01/31/2012
Ad hoc update

Ad hoc release according to § 15 WpHG:

STADA: Purchase of a generics business in Switzerland successfully concluded
More information
 
01/27/2012
Ad hoc update

Ad hoc release according to § 15 WpHG:

STADA and Grünenthal agreed on the purchase of a branded product portfolio also for the EU markets in Central Europe at a lower purchase price
More information
 
01/01/2012
Ad hoc update

Ad hoc release according to § 15 WpHG:

STADA: Withdrawal from purchase of the Grünenthal branded product portfolio in Central Europe
More information
 

 

(c) 2013 STADA Arzneimittel AG, Stadastraße 2-18, 61118 Bad Vilbel, Telefon 06101 603-0, Fax 06101 603-259, e-Mail: info@stada.de